Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Morbidity and mortality in hemodialysis patients with and without erythropoietin treatment: a controlled study.

Bahlmann J, Schöter KH, Scigalla P, Gurland HJ, Hilfenhaus M, Koch KM, Muthny FA, Neumayer HH, Pommer W, Quelhorst E, et al.

Contrib Nephrol. 1991;88:90-106. No abstract available.

PMID:
2040200
2.

Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.

Schaefer RM, Kuerner B, Zech M, Denninger G, Borneff C, Heidland A.

Int J Artif Organs. 1988 Jul;11(4):249-54.

PMID:
3410565
3.

Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.

Ramírez B, Flores A, Pérez F, Córdoba C, García L, Vázquez G.

Transplant Proc. 1991 Apr;23(2):1833-4. No abstract available.

PMID:
2053170
5.

Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.

Albertazzi A, Di Liberato L, Daniele F, Battistel V, Colombi L.

Int J Artif Organs. 1998 Jan;21(1):12-8.

PMID:
9554820
6.
7.

Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin.

Koppensteiner R, Stockenhuber F, Jahn C, Balcke P, Minar E, Ehringer H.

BMJ. 1990 Jun 23;300(6740):1626-7. No abstract available.

8.

[Treatment of anemia in hemodialysis patients using recombinant human erythropoietin: advantages and disadvantages].

Zehnder C, Blumberg A.

Schweiz Med Wochenschr. 1989 Mar 4;119(9):269-75. German.

PMID:
2711161
9.

[Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin].

Schaefer RM.

Krankenpfl J. 1988 Jul-Aug;26(7-8):317-20. German. No abstract available.

PMID:
3419139
10.

[The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].

von Appen K, Klinkmann H.

Urol Nefrol (Mosk). 1990 Nov-Dec;(6):69-70. Review. Russian. No abstract available.

PMID:
2089771
11.

Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin.

Baldamus CA, Steffen AM, Brunner R, Pollok M.

Contrib Nephrol. 1990;82:79-85. No abstract available.

PMID:
2093531
12.

Association between haemoglobin and neopterin concentrations in haemodialysis patients treated with erythropoietin.

Diez-Ruiz A, Weiss G, Artner-Dworzak E, Dittrich PV, Wachter H, Fuchs D.

Eur J Haematol. 1993 Sep;51(3):175-6. No abstract available.

PMID:
8405333
13.

Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus.

Nakatsuka K, Hino M, Miki T, Nishizawa Y, Tabata T, Inoue T, Morii H.

Diabetes Care. 1990 Nov;13(11):1130-1. No abstract available.

PMID:
2261828
14.

[Treatment of anemia in children undergoing chronic hemodialysis with recombinant human erythropoietin].

Rendo P, Biscigniano L, Turconi A, Sánchez Avalos JC, Greco J.

Medicina (B Aires). 1994;54(5 Pt 1):392-8. Spanish.

PMID:
7658972
15.

Effect of recombinant human erythropoietin on hospitalization of hemodialysis patients.

Churchill DN, Muirhead N, Goldstein M, Posen G, Fay W, Beecroft ML, Gorman J, Taylor DW.

Clin Nephrol. 1995 Mar;43(3):184-8.

PMID:
7774076
16.

[Treatment of anemia in chronically dialyzed patients].

Moynot A.

Nephrologie. 1998;19(3):125-7. Review. French. No abstract available.

PMID:
9633055
17.

Anemia in hemodialysis patients: variables affecting this outcome predictor.

Madore F, Lowrie EG, Brugnara C, Lew NL, Lazarus JM, Bridges K, Owen WF.

J Am Soc Nephrol. 1997 Dec;8(12):1921-9.

18.

Recombinant human erythropoietin: 18 months' experience in hemodialysis patients.

Canaud B, Polito-Bouloux C, Garred LJ, Rivory JP, Donnadieu P, Taib J, Florence P, Mion C.

Am J Kidney Dis. 1990 Feb;15(2):169-75.

PMID:
2301388
19.

Effect of hemodialysis and recombinant human erythropoietin on determinants of blood viscosity.

Shand BI, Buttimore AL, Lynn KL, Bailey RR, Robson RA.

Ren Fail. 1994;16(3):407-13.

PMID:
8059023
20.

Changes in blood and plasma volume during treatment with recombinant human erythropoietin.

Fogh-Andersen N, Eidemak I, Løkkegaard H, Levin Nielsen S.

Scand J Clin Lab Invest Suppl. 1993;214:61-5.

PMID:
8332853

Supplemental Content

Support Center